Literature DB >> 12619017

Human leukocyte antigen-C in short- and long-term liver graft acceptance.

Maria Rosa Moya-Quiles1, Manuel Muro, Alberto Torío, Francisco Sánchez-Bueno, Manuel Miras, Luis Marín, Ana Maria García-Alonso, Pascual Parrilla, Jean Dausset, María Rocío Alvarez-López.   

Abstract

In liver transplantation, rejection is still an important problem, and the role of human leukocyte antigens (HLA) has not been clearly established. At present, the possible involvement of HLA-C antigen in liver transplantation is still unexplored. The aim of this work was to analyze the influence of HLA-C polymorphism on the outcome of liver transplantation. For this purpose, genotyping of 100 orthotopic liver transplant recipient-donor pairs for HLA-C was performed with polymerase chain reaction-sequence-specific primers (PCR-SSPs). Liver recipients were stratified according to the occurrence of acute rejection. Patients without acute rejection were found to have a lower frequency of the HLA-Cw*06 allele compared with those with acute rejection or the control group. Moreover, when the role of HLA-C dimorphism was analyzed, natural killer (NK)1-alloantigens were found to be predominant in recipients without acute rejection. When the match of HLA-C single alleles and NK-alloantigens between donor and recipient was analyzed, it appeared that the frequency of acute rejection gradually decreased with decrease of the number of allele mismatches. Graft survival was increased when the number of mismatches in both HLA-C or NK-alloantigens was lower. In conclusion, the HLA-C locus may play a role in liver graft alloreactivity or allotolerance and, therefore, may be useful to avoid acute rejection and to achieve graft acceptance, resulting in a better final outcome in liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12619017     DOI: 10.1053/jlts.2003.50043

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  7 in total

1.  Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.

Authors:  Varun Saxena; Jennifer C Lai; Jacqueline G O'Leary; Elizabeth C Verna; Robert S Brown; R Todd Stravitz; James F Trotter; Kartik Krishnan; Norah A Terrault
Journal:  Liver Transpl       Date:  2012-05       Impact factor: 5.799

Review 2.  Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis.

Authors:  Xiang Lan; Ming-Man Zhang; Cong-Lun Pu; Chun-Bao Guo; Quan Kang; Ying-Chun Li; Xiao-Ke Dai; Yu-Hua Deng; Qiang Xiong; Zhi-Mei Ren
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 3.  Role of NK, NKT cells and macrophages in liver transplantation.

Authors:  René Fahrner; Felix Dondorf; Michael Ardelt; Utz Settmacher; Falk Rauchfuss
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

4.  Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.

Authors:  Alexis Morice; Béatrice Charreau; Bérangère Neveu; Sophie Brouard; Jean-Paul Soulillou; Marc Bonneville; Elisabeth Houssaint; Nicolas Degauque
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

5.  Human Leukocyte Antigen-C Genotype and Killer Immunoglobulin-like Receptor-Ligand Matching in Korean Living Donor Liver Transplantation.

Authors:  Hyeyoung Lee; Ki Hyun Park; Hye Sun Park; Ji Hyeong Ryu; Jihyang Lim; Yonggoo Kim; Gun Hyung Na; Dong Goo Kim; Eun Jee Oh
Journal:  Ann Lab Med       Date:  2017-01       Impact factor: 3.464

6.  HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Authors:  Bjarte Fosby; Sigrid Næss; Johannes R Hov; James Traherne; Kirsten M Boberg; John Trowsdale; Aksel Foss; Pål-Dag Line; Andre Franke; Espen Melum; Helge Scott; Tom H Karlsen
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

7.  Influence of Preformed Antibodies in Liver Transplantation.

Authors:  Isabel Legaz; Francisco Boix; Manuela López; Rafael Alfaro; José A Galián; Santiago Llorente; Jose A Campillo; Carmen Botella; Pablo Ramírez; Francisco Sánchez-Bueno; José A Pons; María R Moya-Quiles; Alfredo Minguela; Manuel Muro
Journal:  J Clin Med       Date:  2020-03-05       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.